Tandem Diabetes Care, Inc. (TNDM)

NGM – Цена в реальном времени. Валюта: USD

16.24

+0.48 (3.05%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

16.30

+0.06 (0.37%)

После закрытия: Jun 26, 2026, 6:51 PM EDT

08.06.2026

Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

05.06.2026

Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 56.2% in Tandem Diabetes Care (TNDM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

05.06.2026

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TandemMobi--Tandem Diabetes Care receives CE mark for AID systems in Europe to include use in type 1 diabetes during pregnancy and adults with type 2 diabetes.

04.06.2026

Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now

TNDM's pay-as-you-go shift, international expansion and strong liquidity support growth, while macro and reimbursement risks remain.

04.06.2026

3 Stocks to Invest in as Broker Rating Upgrades Signal Upside

Broker upgrades flag upside in Tandem, Dell and CNO Financial as earnings forecasts jump and analysts lift ratings over the past four weeks.

03.06.2026

Tandem Diabetes Valuation: Is 1.1x Sales a Buy?

TNDM trades near 1.1x forward sales as it shifts to pharmacy pay-as-you-go and expands Europe, with a $21 target tied to 1.3x sales.

02.06.2026

TNDM Stock: What to Know About Tandem's 2026 Reset

Tandem Diabetes' Q1 beat, fatter margins and positive cash flow fuel its 2026 reset as it shifts more U.S. pump starts to pay-as-you-go pharmacy.

Видео

No Data

There is no data to display

Пресс-релизы

05.06.2026

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TandemMobi--Tandem Diabetes Care receives CE mark for AID systems in Europe to include use in type 1 diabetes during pregnancy and adults with type 2 diabetes.

07.05.2026

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial guidance for the year ending December 31, 2026. First Quarter 2026 Financial and Strategic Highlights Achieved record first quarter pump shipments, sales and gross margin: Shipments of more than 29,000 pumps worldwide, including 19,000 pumps in the United States Sales o.

27.04.2026

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type 1 diabetes.

27.03.2026

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, March 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Tandem Diabetes Care, Inc. , (“ Tandem " or the "Company") ( NASDAQ:TNDM ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Tandem Diabetes Care, Inc. (TNDM)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now

3 Stocks to Invest in as Broker Rating Upgrades Signal Upside

Tandem Diabetes Valuation: Is 1.1x Sales a Buy?

TNDM Stock: What to Know About Tandem's 2026 Reset

Видео

No Data

Пресс-релизы

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now

3 Stocks to Invest in as Broker Rating Upgrades Signal Upside

Tandem Diabetes Valuation: Is 1.1x Sales a Buy?

TNDM Stock: What to Know About Tandem's 2026 Reset

Видео

No Data

Пресс-релизы

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

Search stocks

Tandem Diabetes Care, Inc. (TNDM)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now

3 Stocks to Invest in as Broker Rating Upgrades Signal Upside

Tandem Diabetes Valuation: Is 1.1x Sales a Buy?

TNDM Stock: What to Know About Tandem's 2026 Reset

Видео

No Data

Пресс-релизы

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now

3 Stocks to Invest in as Broker Rating Upgrades Signal Upside

Tandem Diabetes Valuation: Is 1.1x Sales a Buy?

TNDM Stock: What to Know About Tandem's 2026 Reset

Видео

No Data

Пресс-релизы

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm